Penetration of intravenous hydroxyethyl starch into the cerebrospinal fluid in patients with impaired blood-brain barrier function

Anesthesia and Analgesia

Volumn 96, Issue 4, 2003, Pages 1150-1154

  Dieterich, Hans Jürgen ^a   Reutershan, Jörg ^a   Felbinger, Thomas W ^b,c   Eltzschig, Holger K ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG PENETRATION; FEMALE; HEAD INJURY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

EID: 0037378752     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000050771.72895.66     Document Type: Article

References (27)

1. Guidelines for the management of severe head injury. Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. J Neurotrauma 1996;13:641-734.
2. Zornow MH, Prough DS. Fluid management in patients with traumatic brain injury. New Horiz 1995;3:488-98.
3. Drummond JC, Patel PM, Cole DJ, Kelly PJ. The effect of the reduction of colloid oncotic pressure, with and without reduction of osmolality, on post-traumatic cerebral edema. Anesthesiology 1998;88:993-1002.
4. Dieterich HJ, Kraft D, Sirtl C, et al. Hydroxyethyl starch antibodies in humans: incidence and clinical relevance. Anesth Analg 1998;86:1123-6.
5. Chorny I, Bsorai R, Artru AA, et al. Albumin or hetastarch improves neurological outcome and decreases volume of brain tissue necrosis but not brain edema following closed-head trauma in rats. J Neurosurg Anesthesiol 1999;11:273-81.
6. Kaplan SS, Park TS, Gonzales ER, Gidday JM. Hydroxyethyl starch reduces leukocyte adherence and vascular injury in the newborn pig cerebral circulation after asphyxia. Stroke 2000;31:2218-23.
7. Handschu R, Garling A, Heuschmann PU, et al. Acute stroke management in the local general hospital. Stroke 2001;32:866-70.
8. Goetz CG, Papper EJ, Schmitt B. Textbook of clinical neurology. 1st ed. Philadelphia, PA: WB Saunders Co, 1999.
9. Sirtl CJ, Schimetta W, Buettner T, et al. Hydroxyethyl starch: does it penetrate into the cerebrospinal fluid? J Pharmakol u Ther 2000;1:4-9.
10. Chlenov MA, Iarovaia SM, Alekseeva GS, et al. [Determination of the molecular weight of microbial polysaccharides using high performance exclusion chromatography]. Prikl Biokhim Mikrobiol 1987;23:515-21.
11. Ferber HP, Nitsch E, Forster H. Studies on hydroxyethyl starch. II. Changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3, and 200/0.1 after infusion in serum and urine of volunteers. Arzneimittelforschung 1985;35:615-22.
12. Todd NV, Graham DI. Blood-brain barrier damage in traumatic brain contusions. Acta Neurochir Suppl (Wien) 1990;51:296-9.
13. Bullock R, Statham P, Patterson J, et al. The time course of vasogenic oedema after focal human head injury: evidence from SPECT mapping of blood brain barrier defects. Acta Neurochir Suppl (Wien) 1990;51:286-8.
14. Lang DA, Hadley DM, Teasdale GM, et al. Gadolinium-DTPA enhanced magnetic resonance imaging in human head injury. Acta Neurochir Suppl (Wien) 1990;51:293-5.
15. Germano A, d'Avella D, Imperatore C, et al. Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 2000;142:575-80;Discussion 80-1.
16. Rudehill A, Gordon E, Ohman G, et al. Pharmacokinetics and effects of mannitol on hemodynamics, blood and cerebrospinal fluid electrolytes, and osmolality during intracranial surgery. J Neurosurg Anesthesiol 1993;5:4-12.
17. Anderson P, Boreus L, Gordon E, et al. Use of mannitol during neurosurgery: interpatient variability in the plasma and CSF levels. Eur J Clin Pharmacol 1988;35:643-9.
18. Nau R, Desel H, Lassek C, et al. Slow elimination of mannitol from human cerebrospinal fluid. Eur J Clin Pharmacol 1997;53: 271-4.
19. Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 1992;77:584-9.
20. Dieterich HJ. [Colloids in intensive care]. Anaesthesist 2001;50: 54-68.
21. Mayhan WG. Regulation of blood-brain barrier permeability. Microcirculation 2001;8:89-104.
22. Collard CD, Park KA, Montalto MC, et al. Neutrophil-derived glutamate regulates vascular endothelial barrier function. J Biol Chem 2002;277:14801-11.
23. Spellerberg B, Prasad S, Cabellos C, et al. Penetration of the blood-brain barrier: enhancement of drug delivery and imaging by bacterial glycopeptides. J Exp Med 1995;182:1037-43.
24. Chi OZ, Lu X, Wei HM, et al. Hydroxyethyl starch solution attenuates blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. Anesth Analg 1996; 83:336-41.
25. Wisselink W, Patetsios P, Panetta TF, et al. Medium molecular weight pentastarch reduces reperfusion injury by decreasing capillary leak in an animal model of spinal cord ischemia. J Vasc Surg 1998;27:109-16.
26. Schell RM, Cole DJ, Schultz RL, Osborne TN. Temporary cerebral ischemia: effects of pentastarch or albumin on reperfusion injury. Anesthesiology 1992;77:86-92.
27. Moshkin AV. [The permeability of the blood-cerebrospinal fluid barrier in the first 24 hours after cranio-cerebral injury]. Lab Delo 1990:47-50.